SEARCH

SEARCH BY CITATION

References

  • 1
    Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker, B, editor. Quality of Life Assessment in Clinical Trials. New York: Raven Press 1990, 1124.
  • 2
    Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997;99: S742S749.
  • 3
    Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94: 182188.
  • 4
    Van Der Molen T, Postma Ds, Schreurs Aj, Bosveld He, Sears Mr, Meyboom De Jong B. Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res 1997;6: 353361.
  • 5
    Bousquet J, Knani J, Dhivert H et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149: 371375.
  • 6
    Lennaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults (In Process Citation). Am J Respir Crit Care Med 2000;162: 13911396.
  • 7
    Rajagopalan R, Anderson RT. The profile of a patient with contact dermatitis and a suspicion of contact allergy (history, physical characteristics, and dermatology-specific quality of life). Am J Contact Dermat 1997;8: 2631.
  • 8
    Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19: 210216.
  • 9
    Bousquet J, Duchateau J, Pignat JC etal. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98: 309316.
  • 10
    Pariente PD, Lepen C, Los F, Bousquet J. Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis. Pharmacoeconomics 1997;12: 585595.
  • 11
    Johansson SG, O'B Hourihane J, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56: 813824.
  • 12
    international rhinitis management working group. International Consensus Report on the diagnosis and management of rhinitis. Allergy 1994;49: 134.
  • 13
    Brand PL, Quanjer PH, Postma DS et al. the dutch chronic non-specific lung dis (cnsld) study group. Interpretation of bronchodilator response in patients with obstructive airways disease. Thorax 1992;47: 429436.
  • 14
    Malo JL, Pineau L, Cartier A, Martin RR. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis 1983;128: 811.
  • 15
    Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatovener (Stockholm) Supplement 1980;92: 4447.
  • 16
    Finlay AY. Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 1996;135: 509515.
  • 17
    Aaronson NK, Muller M, Cohen PD et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998;51: 10551068.
  • 18
    Keller SD, Bayliss MS, Ware JE Jr, Hsu MA, Damiano AM, Goss TF. Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periods. Health Serv Res 1997;32: 367384.
  • 19
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30: 473483.
  • 20
    Ware JE Jr, Keller SD, Gandek B, Brazier JE, Sullivan M. Evaluating translations of health status questionnaires. Methods from the IQOLA project International Quality Life Assessment. Int J Technol Assess Health Care 1995;11: 525551.
  • 21
    Ware JE Jr, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res 1998;7: 235244.
  • 22
    Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth van Wijk R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997;27: 796801.
  • 23
    Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs (see Comments). BMJ 1991;302: 265269.
  • 24
    Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, New Yersey: Lawrence Erlbaum Associates 1988.
  • 25
    Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52: 187192.